Melatonin megadoses?

#611

TL;DR

Topical melatonin has a surprising amount of clinical evidence for skin anti-aging, mainly through UV protection, antioxidant activity, and mitochondrial support (mitophagy). Applied before sun exposure, it can meaningfully blunt UV-induced skin inflammation and DNA damage, and separate studies show benefits for reducing radiation dermatitis in cancer patients, improving skin hydration/roughness, and even modestly regrowing hair in androgenic alopecia. It’s not a sunscreen replacement and weaker than retinoids for structural remodeling, but it looks like a legitimate complementary tool, especially as a pre-sun antioxidant or nighttime cream.

Actionable Insights

  • Timing is everything. Melatonin gel applied 15 minutes before UV exposure almost completely suppressed UV-induced skin reddening in one study. Applied after exposure, it did essentially nothing. If you’re going to use it for photoprotection, apply it before you go outside, not after you get sunburned.
  • It doesn’t replace sunscreen. Since ~90% of extrinsic skin aging is UV-driven, sunscreen still does the heavy lifting during the day. Treat topical melatonin as a complementary layer of oxidative stress defense, not a substitute.
  • Concentration depends on your goal. The video cites 0.01% for basic skin penetration data, 0.1% as having the clearest human anti-aging evidence, 0.5-12.5% for photoprotection studies, and 2.5% as having the strongest overall clinical evidence.
  • Nighttime cream is the more evidence-backed use case. A 12-week nighttime cream (melatonin + carnosine + Helichrysum italicum extract) reduced brown spot count (~5.5%), UV spots (~13.2%), and wrinkle count (up to ~18.9%) in 117 people. Worth noting this was a combination formula, not melatonin alone.
  • For hair loss (androgenic alopecia), 0.1% solution once daily for 90-180 days is the dosage with the most supportive data, alongside a lower-concentration option (~0.0033%). Effects on hair density and anagen (growth phase) hair counts were reported to persist even after stopping treatment, though these studies lacked control groups, so treat this as promising rather than confirmed.

Key Points

UV protection mechanism:

  • Clinical evidence for topical melatonin spans UV protection, reduced radiodermatitis, reduced UV-induced DNA damage, improved skin barrier function, reduced inflammation/redness, and reduced transepidermal water loss.
  • Original 1990s studies used 0.05-0.5% melatonin gel on UVB-irradiated skin; 0.5% performed best, with effects concentrated in “strong reactor” subgroups 8 hours post-irradiation.
  • A 2016 study on women undergoing cancer radiotherapy found melatonin cream reduced grade 1-2 radiation dermatitis occurrence (59% vs 90% in controls), with women over 50 showing even better outcomes (56% vs 100%).

Anti-aging mechanisms:

  • Melatonin acts as a potent antioxidant, scavenging free radicals directly and upregulating endogenous defenses (SOD, glutathione peroxidase).
  • It has immunomodulatory effects relevant to dermatitis and wound healing, and has shown skin cancer cell growth inhibition via apoptosis in mechanistic studies.
  • A less-discussed angle: melatonin activates mitophagy (mitochondrial cell turnover), increases NAD levels, and restores proline synthesis, supporting collagen regeneration. This ties into an underappreciated driver of skin aging, mitochondrial dysfunction.

Comparison to other actives:

  • vs. Sunscreen: complementary, not a replacement.
  • vs. Retinoids: weaker evidence for structural remodeling; retinol still wins for wrinkle reduction.
  • vs. Vitamin C/E/ferulic acid: mechanistically competitive in oxidative defense, but far less clinically validated.
  • vs. Niacinamide: less evidence for barrier function and tone; niacinamide still preferable for those specific goals.

Evidence quality caveat: Several of the most positive studies (the 2012 wrinkle study, the 2023 nighttime cream study) combined melatonin with other actives (vitamin E, betaglucans, carnosine, Helichrysum extract), so isolating melatonin’s standalone contribution is difficult. The hair growth studies also generally lacked control groups. The mechanistic rationale is solid, but standalone-melatonin human data is thinner than the framing suggests.

#612

I currently use topical Minoxidil to which I add Rapamycin and stevia. Seems like adding Melatonin might prove an interesting addition by possibly addressing an otherwise unaddressed factor.

I asked ChatGPT

Given your particular situation, I think topical melatonin deserves consideration—not because the evidence equals that for minoxidil or finasteride, but because:

  1. it appears to act through mechanisms that only partially overlap with your current regimen,
  2. it has an unusually favorable safety profile,
  3. you have already demonstrated a better-than-average response to an experimental combination (minoxidil + rapamycin).

That does not mean it will necessarily add benefit, but biologically it makes more sense than many of the compounds commonly added to topical hair formulas.

Current regimen

Your present topical approach already appears to target several major aspects of androgenetic alopecia.

Agent Likely primary action
Minoxidil Potassium-channel opening, VEGF, prolongation of anagen
Rapamycin mTOR modulation, stem-cell homeostasis, reduced senescence/inflammation (experimental)
Stevia Highly speculative; possible anti-inflammatory and microbiome effects

Melatonin would add something different.

What topical melatonin actually does

Hair follicles are unusual.

They do not merely respond to circulating melatonin.

They synthesize melatonin locally, express melatonin receptors, and possess an intrinsic melatonin antioxidant system. Hair follicles therefore appear to use melatonin as a local signaling molecule rather than simply responding to pineal secretion.

Current evidence suggests several mechanisms.

1. Antioxidant protection

Probably the strongest mechanism.

Hair follicles generate large amounts of reactive oxygen species because matrix keratinocytes divide extraordinarily rapidly.

Melatonin

  • scavenges free radicals
  • activates endogenous antioxidant enzymes
  • protects mitochondrial DNA
  • reduces lipid peroxidation

These actions could preserve follicular function under chronic oxidative stress.

2. Mitochondrial support

This interests me even more.

Melatonin accumulates inside mitochondria.

It appears to

  • stabilize mitochondrial membranes
  • improve ATP production
  • reduce mitochondrial oxidative injury
  • support mitophagy under stress

Since hair follicles rank among the body’s most metabolically active tissues, this represents a plausible biological target.

3. Prolongation of anagen

Multiple studies suggest that melatonin shifts follicles toward the growth phase.

Rather than dramatically increasing growth rate, it appears to reduce premature transition into catagen.

4. Anti-inflammatory effects

AGA increasingly appears to involve chronic perifollicular inflammation.

Melatonin decreases several inflammatory cytokines and oxidative mediators.

This may complement rapamycin rather than duplicate it.

Human clinical evidence

The evidence remains modest but better than many realize.

Randomized placebo-controlled trial

The best study remains the 2004 Fischer trial.

  • 40 women
  • placebo-controlled
  • double blind
  • 0.1% topical melatonin
  • once daily
  • six months

Result:

Statistically significant improvement in anagen hair proportion in several measured scalp regions compared with placebo.

Open-label studies

Several subsequent studies involving both men and women reported

  • increased hair density
  • increased hair counts
  • reduced shedding
  • improved hair thickness

These studies lack placebo controls, so they provide supportive—but weaker—evidence.

Recent review

A 2023 review identified 11 human studies (over 2,200 participants collectively).

Overall conclusion:

  • most studies reported improved hair growth
  • several reported improved density
  • some reported thicker shafts

The authors concluded that topical melatonin appears promising, but larger randomized trials remain necessary.

That seems like a fair assessment.

Would it complement your regimen?

I think yes.

Mechanistically, your regimen looks like this:

Minoxidil
        ↓
vascular signaling
potassium channels
VEGF

Rapamycin
        ↓
mTOR
cellular aging
autophagy

Melatonin
        ↓
mitochondria
oxidative stress
circadian follicle biology

Those represent largely independent pathways.

That raises the possibility—not proof—of additive effects.

Interaction with rapamycin

This interests me the most.

Both agents influence

  • autophagy
  • mitochondrial quality
  • oxidative stress

However, they act differently.

Rapamycin primarily alters nutrient-sensing pathways.

Melatonin primarily protects mitochondria from oxidative injury.

Those mechanisms appear complementary rather than redundant.

There is currently no evidence that topical melatonin interferes with topical rapamycin.

Could melatonin interfere with minoxidil?

Nothing currently suggests this.

If anything, improved follicular mitochondrial function could theoretically support the proliferative response induced by minoxidil.

Again, this remains theoretical.

Vehicle considerations

This may matter more than the melatonin itself.

Most positive studies used

  • ethanol
  • propylene glycol
  • hydroalcoholic vehicles

Those vehicles closely resemble many commercial minoxidil formulations.

Therefore, if adding melatonin directly into your topical minoxidil solution, compatibility seems chemically plausible, although I have not seen published stability testing for that exact combination.

I would avoid assuming long-term stability without data.

Dosing

Human evidence clusters around two concentrations: 0.1%
Most studied.

or: 0.0033%
Some supportive studies.

The higher concentration has the stronger evidence base.

Safety

Topical melatonin appears remarkably well tolerated.

Reported adverse effects have generally been limited to

  • mild scalp irritation
  • occasional transient itching

Importantly,

systemic melatonin concentrations remained within normal nighttime physiological ranges in the randomized trial despite daily application.

My assessment for your specific case

Given what I know about your situation:

  • age 74
  • ongoing oral finasteride
  • oral minoxidil
  • topical minoxidil
  • topical rapamycin
  • documented improvement with the current regimen
  • willingness to use evidence-informed experimental approaches

I would rate topical melatonin as:

Biological plausibility: ★★★★★

Human evidence: ★★★☆☆

Safety: ★★★★★

Probability of a meaningful additional benefit: ★★☆☆☆ to ★★★☆☆

In other words, I would not expect melatonin to produce another dramatic improvement comparable to initiating minoxidil, but I do think it has a reasonable chance of incrementally increasing hair density or prolonging anagen through mechanisms not fully addressed by your current regimen.

One additional thought

Your current topical formulation already contains an unusual combination of active agents. Before simply adding melatonin into the same bottle, I would first want to evaluate the chemical stability and compatibility of melatonin with:

  • minoxidil,
  • rapamycin,
  • the solvent system,
  • and stevia extract.

That question has a different answer than whether melatonin itself works. If the mixture degrades one of the actives or reduces penetration, it could negate any potential benefit. Assessing formulation compatibility would be the logical next step before modifying a regimen that is already producing meaningful results.

1 Like